Brand semaglutide
Sold by RoenRx · Injection, pen · every brand semaglutide record
Price
| Term | Published rate | Charged today |
|---|---|---|
| With insurance, copay as low as Price conditions have not been established; the quoted figure is not a verified recurring rate. “Ozempic®, Wegovy®, Zepbound™, and Mounjaro® as low as $25/month” | $25Published figure | Charged todayNot verified |
Price sources
- With insurance, copay as low as · roenrx.com — read September 2026
We earn nothing from this link. It opens RoenRx's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| States | All 50 states |
|---|---|
| Prescriber | Both |
| Cancellation | You can cancel your membership at any time directly through your RoenRx portal. Simply go to your profile, select “Manage membership,” then choose “Manage plan” to complete the cancellation. |
| Membership | Required. $39 per month. Your first month of membership is currently discounted to $39 and includes personalized medical care, one-on-one coaching, and support from our insurance coordination team to help obtain coverage for prescribed medications when possible. |
Not yet checked: pharmacy and consult fee.
Recorded from roenrx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — RoenRx runs two separate pricing tracks: a base membership ($39 first month, discounted) with compounded medication billed separately ($151/mo semaglutide, $216/mo tirzepatide, quarterly), and a "Doctor + GLP-1" bundle where medication is included in the monthly fee ($297/mo semaglutide, $449/mo tirzepatide after a higher first month). Both are reported. Notably, the site's own FAQ text and one page header ("Your Zealthy treatment plan starts here") repeatedly say "Zealthy" and "Zealthy members" instead of RoenRx -- apparent leftover white-label template text pointing to Zealthy as the underlying platform. FDA-approved brand prices (Ozempic/Wegovy/Zepbound/Mounjaro at $25/mo) are explicitly insurance-copay prices, reported separately per the brief's insurance-vs-cash rule.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.